venetoclax,rituximab,glofitamab,pirtobrutinib,brexucabtagene autoleucel
loxo oncology,gilead,roche,eli lilly,abbvie
['bruin trial', 'pirto', 'glofitamab', 'bruin', 'zuma-2']
in this episode of #oncliveonair, , of , details data being presented at #ash22, the bruin trial, the potential for car t-cell therapy as evidenced in the zuma-2 trial, and updates in immunotherapy. 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.